Nemaura Pharma owns/has exclusive rights to all of its technologies. The technology platforms represent a valuable partnering opportunity for product-life-cycle extension or a new, proprietary reformulation platform. The company is privately owned and has been funded to date by its shareholders, and government grants. Nemaura is developing a pipeline of both own branded generic products that offer both clinical and commercial advantages, as well as co-development of molecules for delivery using Nemaura’s platform technologies.

If you would like to be kept informed of future investment opportunities in Nemaura Pharma then please contact us at ir@nemaura.co.uk

HOME | ABOUT | TECHNOLOGIES | PIPELINE | MANAGEMENT
ADVISORY BOARD | INVESTORS | CAREERS | CONTACT

Registered Name: Nemaura Pharma Limited
Country of Registration: England and Wales
Registered Office: Holywell Park, Loughborough, LE11 3AQ, United Kingdom
Registered Number: 5636878
© 2011 Nemaura Pharma